Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin and Alteplase in Acute Ischemic Hemispheric Stroke
NCT00840671Phase 3Completed
- Sponsor
- EVER Pharma
- Start
- Oct 2005
- Primary completion
- Mar 2008
- Modality
- Native Peptides
- Countries
- 5
01
Overview
A Phase 3 trial of cerebrolysin in ischemic stroke, sponsored by EVER Pharma. Started Oct 2005; status: completed.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00840671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840671.